drug;gene_symbol;alteration;exact_alteration;mutation_specification;groupSelumetinib;MAP2K1;SNV;amino_acid_position;68-361;group1Selumetinib;MAP2K1;CNA;amplification;NA;group1Selumetinib;MAP2K2;SNV;NA;NA;group1Selumetinib;MAP2K2;CNA;amplification;NA;group1Idelalisib;PIK3CA;SNV;NA;NA;group1Idelalisib;PIK3CA;CNA;amplification;NA;group1Trastuzumab;ERBB2;CNA;amplification;NA;group1Trastuzumab;ERBB2;expression;up;NA;group1Vemurafenib;BRAF;SNV;amino_acid_variant;V600E;group1Vemurafenib;BRAF;SNV;amino_acid_variant;V600K;group1Olaparib;BRCA1;CNA;deletion;NA;group1Olaparib;BRCA1;SNV;NA;NA;group1Olaparib;BRCA2;CNA;deletion;NA;group1Olaparib;BRCA2;SNV;NA;NA;group1Vandetanib;ERBB3;SNV;NA;NA;group2Vandetanib;ERBB2;SNV;NA;NA;group2Vandetanib;EGFR;SNV;NA;NA;group2Vandetanib;ABL2;SNV;NA;NA;group2Vandetanib;ABL1;SNV;;NA;group2Vandetanib;KDR;SNV;NA;NA;group2Vandetanib;RIT1;SNV;NA;NA;group2Vandetanib;KIT;SNV;NA;NA;group2"""""";KRAS;SNV;genomic_position;12:25358500-25359500;group2"""""";KRAS;SNV;genomic_position;12:25359000-25359000;group2"""""";KRAS;SNV;dbSNP_rs;rs121913535;group2"""""";KRAS;SNV;genomic_position;12:25398225-25398300;group2"""""";HRAS;SNV;amino_acid_position;5-165;group2"""""";NRAS;SNV;amino_acid_position;5-165;group2"""""";NRAS;SNV;amino_acid_position;150-189;group2Erlotinib;EGFR;SNV;mutation_type;missense;group2"""""";EML4-ALK;fusion;;;group2"""""";PML;fusion;;;group2